The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Caffeine and Cardiometabolic Health: Evidence, Controversies, and Clinical Considerations
Abstract
Caffeine is the most widely consumed psychoactive substance globally, making its cardiometabolic effects particularly relevant, especially in individuals with established cardiovascular disease. This narrative review presents an overview of the current literature on caffeine and its impact on cardiometabolic risk factors by encompassing not only clinical but also mechanistic studies, eventually providing practical hints for clinical practice. A structured literature search was conducted via MEDLINE on caffeine and coffee in relation to cardiovascular health and disease. In patients with hypertension, caffeine intake is generally considered safe within certain limits, though individual factors, such as advanced age and CYP1A2 gene variants, may increase sensitivity. Caffeine’s effects on the lipid profile vary by preparation method, with filtered coffee being more favorable than unfiltered forms. Although caffeine can acutely impair glycemic control in patients with diabetes, long-term intake may reduce complications like metabolic dysfunction–associated steatohepatitis, though it may also worsen diabetic renal disease. Caffeine consumed before exercise may impair coronary vasodilation in patients with coronary artery disease and should be avoided in this setting. Although moderate intake is safe for most adults, excessive caffeine consumption, especially from energy drinks containing additional stimulants, can pose severe cardiovascular risks for vulnerable individuals, such as those with arrhythmias, hypertension, or genetic susceptibilities. Despite its widespread use, few health authorities and scientific societies offer detailed guidance on caffeine consumption. Significant heterogeneity in study design, dosage, and patient selection limits the ability to translate findings into clinical recommendations. A more personalized approach, incorporating genetic variability and standardized dosing, may help optimize both safety and potential therapeutic benefits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In other contexts, however, it may transiently elevate blood pressure, alter vascular reactivity, and impose additional cardiovascular strain in susceptible populations [21,22].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [22]
Citations
Cites
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Nehlig, A., Daval, J.-L., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,461
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1379 · Cited by 577
Clark, I., & Landolt, H. P. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.01.006 · Cited by 499
Mesas, A. E., Leon-Muñoz, L. M., Rodriguez-Artalejo, F., & Lopez-Garcia, E. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.016667 · Cited by 350
Lopez-Garcia, E., van Dam, R. M., Qi, L., & Hu, F. B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.888 · Cited by 256
Caffeine effects on systemic metabolism, oxidative-inflammatory pathways, and exercise performance
Barcelos, R. P., Lima, F. D., Carvalho, N. R., Bresciani, G., & Royes, L. F. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.05.005 · Cited by 218
Xu, Y., Zhang, M., Wu, T., Dai, S., Xu, J., & Zhou, Z. (2015) · Food & Function · doi:10.1039/c4fo00970c · Cited by 213
Effects of coffee/caffeine on brain health and disease: What should I tell my patients?
Nehlig, A. (2016) · Practical Neurology · doi:10.1136/practneurol-2015-001162 · Cited by 205
The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials
Cai, L., Ma, D., Zhang, Y., Liu, Z., & Wang, P. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.68 · Cited by 204
Cited by
Geng, H., Zhou, Z., Meng, L., Zhuang, M., & Zhao, Y. (2026) · Metabolites · doi:10.3390/metabo16070478 · Cited by 2
“In other contexts, however, it may transiently elevate blood pressure, alter vascular reactivity, and impose additional cardio-vascular strain in susceptible populations [21,22].”
Travmaya Bağlı Maksiller Santral Kesici Eksikliğinin Ortodontik Yönetimi: Olgu Sunumu
Cengiz, S. M., Baki, Ö. F., & Cengiz, A. F. (2026) · Mersin Üniversitesi Açık Erişim Sistemi/Mersin University Open Access System
Metadata
- Authors
- Kayikcioglu, M., & Ozkan, H. S.
- Affiliations
- Ege University (TR)
- Department of Psychiatry and Psychotherapy, University Hospital Schleswig-Holstein , Lubeck,
- Venue
- Nutrition Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2026-03-13
- ISSN
- 0029-6643 (ISSN-L)
- 1753-4887
- OpenAlex
- W7135209916
- Cited by
- 1
- References
- 128
- Citations by year
- 2026: 1
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- caffeine, cardiometabolic health, cardiovascular disease, hypertension, coffee, lipid profile, filtered coffee, glycemic control, diabetes mellitus, nonalcoholic steatohepatitis, diabetic renal disease, coronary artery disease, physical activity, energy drinks, cardiac arrhythmias, caffeine safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeine and Cardiometabolic Health: Evidence, Controversies, and Clinical Considerations. https://app.cochat.ai/papers/10.1093/nutrit/nuag018
- The paper
- Kayikcioglu, M., & Ozkan, H. S. (2026). Caffeine and Cardiometabolic Health: Evidence, Controversies, and Clinical Considerations. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuag018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.